This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Eli Lilly & Co. slipped 5.6% to $775.12 on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.8% to 5,606.91 and Dow Jones Industrial Average falling 0.9% to 40,829.00.
This was the stock's second consecutive day of losses.
Eli Lilly & Co. closed 20.3% short of its 52-week high of $972.53, which the company reached on August 22nd.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson fell 0.3% to $154.47, Pfizer Inc. fell 4.1% to $22.88, and AbbVie Inc. fell 4.55% to $187.15.
Trading volume totaled 5.9 million, compared to the 50-day average of 3.9 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 06, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。